Litwiniuk, A.; Baranowska-Bik, A.; Domańska, A.; Kalisz, M.; Bik, W.
Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases. Pharmaceuticals 2021, 14, 1221.
https://doi.org/10.3390/ph14121221
AMA Style
Litwiniuk A, Baranowska-Bik A, Domańska A, Kalisz M, Bik W.
Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases. Pharmaceuticals. 2021; 14(12):1221.
https://doi.org/10.3390/ph14121221
Chicago/Turabian Style
Litwiniuk, Anna, Agnieszka Baranowska-Bik, Anita Domańska, Małgorzata Kalisz, and Wojciech Bik.
2021. "Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases" Pharmaceuticals 14, no. 12: 1221.
https://doi.org/10.3390/ph14121221
APA Style
Litwiniuk, A., Baranowska-Bik, A., Domańska, A., Kalisz, M., & Bik, W.
(2021). Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases. Pharmaceuticals, 14(12), 1221.
https://doi.org/10.3390/ph14121221